SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FAINARDI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.207
AS - Asia 8.006
EU - Europa 4.086
SA - Sud America 1.143
AF - Africa 201
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 14
Totale 27.674
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.946
SG - Singapore 3.207
CN - Cina 2.042
BR - Brasile 909
VN - Vietnam 886
IT - Italia 662
DE - Germania 649
UA - Ucraina 631
HK - Hong Kong 618
GB - Regno Unito 498
TR - Turchia 416
FI - Finlandia 346
PL - Polonia 320
FR - Francia 242
SE - Svezia 198
JP - Giappone 192
RU - Federazione Russa 190
IN - India 146
CA - Canada 126
MX - Messico 103
ID - Indonesia 92
BD - Bangladesh 82
ZA - Sudafrica 76
AR - Argentina 70
IQ - Iraq 65
BE - Belgio 57
NL - Olanda 56
AT - Austria 53
CO - Colombia 44
PK - Pakistan 39
MA - Marocco 36
ES - Italia 34
CZ - Repubblica Ceca 33
EC - Ecuador 32
LT - Lituania 26
UZ - Uzbekistan 26
VE - Venezuela 25
SA - Arabia Saudita 24
PY - Paraguay 20
PH - Filippine 18
IR - Iran 17
CL - Cile 16
ET - Etiopia 16
KE - Kenya 16
MY - Malesia 16
AE - Emirati Arabi Uniti 15
AU - Australia 14
EG - Egitto 13
NP - Nepal 13
DZ - Algeria 12
UY - Uruguay 12
IE - Irlanda 10
NO - Norvegia 10
PE - Perù 10
PT - Portogallo 10
JO - Giordania 9
RO - Romania 9
TN - Tunisia 9
AZ - Azerbaigian 8
KR - Corea 8
KZ - Kazakistan 8
LB - Libano 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AL - Albania 6
BG - Bulgaria 6
CH - Svizzera 6
EU - Europa 6
IL - Israele 6
NG - Nigeria 6
OM - Oman 6
AO - Angola 5
GR - Grecia 5
HN - Honduras 5
HR - Croazia 5
JM - Giamaica 5
GE - Georgia 4
MN - Mongolia 4
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
CY - Cipro 2
GD - Grenada 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
Totale 27.645
Salva come PNG Salva come JPEG
Città #
Singapore 1.979
Ashburn 1.713
Woodbridge 1.338
Fairfield 1.093
San Jose 933
Chandler 768
Houston 734
Jacksonville 678
Beijing 648
Santa Clara 625
Hong Kong 609
Ann Arbor 561
Wilmington 395
Seattle 385
Cambridge 360
Warsaw 306
Ho Chi Minh City 295
Los Angeles 252
New York 240
Izmir 236
Nanjing 219
Dallas 210
Ferrara 198
Hanoi 194
Tokyo 189
Princeton 180
Milan 149
Munich 146
Lauterbourg 143
Helsinki 139
Boardman 122
Shanghai 116
Council Bluffs 98
São Paulo 94
San Diego 91
The Dalles 86
Addison 81
Dearborn 80
Buffalo 70
Mexico City 67
Nanchang 67
Orem 67
Turku 66
Shenyang 63
London 62
Jakarta 61
Bremen 59
Brooklyn 58
Brussels 57
Tianjin 52
Chicago 51
Montreal 51
Jiaxing 50
Changsha 47
Hebei 46
Chennai 45
Hefei 43
Atlanta 41
Da Nang 41
Denver 41
Stockholm 41
Johannesburg 38
Norwalk 38
Poplar 38
Vienna 35
Haiphong 34
Falls Church 32
Toronto 32
Phoenix 31
San Francisco 31
Baghdad 30
Manchester 30
Amsterdam 29
Brno 29
Frankfurt am Main 29
Rio de Janeiro 29
San Mateo 28
Boston 27
Ankara 26
Ningbo 26
Guangzhou 25
Jinan 24
Nuremberg 24
Rome 24
Tashkent 24
Zhengzhou 24
Bologna 23
Moscow 23
Orange 23
Redwood City 23
Biên Hòa 22
Columbus 22
Auburn Hills 21
Falkenstein 21
Hải Dương 21
Brasília 19
Kunming 19
Curitiba 18
Mountain View 18
Mumbai 18
Totale 18.957
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 412
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 272
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 260
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 250
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 247
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 247
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 245
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 245
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 241
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 240
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 238
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 234
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 234
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 233
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 227
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 224
HLA-G Molecules in Autoimmune Diseases and Infections 223
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 223
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 222
Survival prediction in high-grade gliomas using CT perfusion imaging 219
Emerging topics and new perspectives on HLA-G 218
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 214
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 213
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 212
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 210
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 209
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 207
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 205
Leptin/adiponectin ratio predicts post-stroke neurological outcome 205
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 203
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 203
Cerebrospinal fluid analysis and the determination of oligoclonal bands 201
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 200
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 200
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 195
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 194
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 193
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 192
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 186
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 186
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 186
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 186
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 185
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 184
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 182
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 181
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 181
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 180
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 180
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 178
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 178
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 177
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 176
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 176
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 175
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 174
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 174
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 174
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 172
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 172
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 171
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 171
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 171
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 169
Some basic aspects of HLA-G biology. 168
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 168
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 165
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 163
Role of Toll-like receptors in patients with multiple sclerosis and Chlamydophila pneumoniae infection 162
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 162
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 161
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 161
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 160
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 159
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 159
Neurofilament ELISA validation 158
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 156
Le catene leggere libere liquorale sclerosi multipla 154
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 152
New insights into HLA-G and inflammatory diseases 152
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 152
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 149
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 149
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 149
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 148
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 148
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 146
Endovascular Thrombectomy for Acute Ischemic Stroke beyond 6 Hours from Onset: A Real-World Experience 145
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 145
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 143
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 143
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 141
Cerebrospinal fluid free Kappa and Lambda lights chains in MS. A qualitative analysis 141
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 141
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 141
An unusual cause of a common symptom: Pyomyositis presenting with sciatica 140
An evaluation of quantitative env and qualitative pol rt-pcr detection of the multiple sclerosis (MS) -associated retrovirus in Europe 140
Congruence between clinical diagnosis and DATSCAN imaging in 150 consecutive patients. 139
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 138
Chlamydia pneumonia-specific CFS-restricted oligoclonal IgG bands are associated to a subset of patients with prosessive forms of multiple sclerosis. 136
Totale 18.669
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.095
Totale 123.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021681 0 0 0 0 0 0 0 0 0 270 283 128
2021/20221.609 84 183 96 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/20254.035 103 92 310 158 530 353 98 156 767 477 567 424
2025/202610.513 1.131 456 853 1.429 1.707 771 1.458 620 1.033 1.055 0 0
Totale 27.968